Senior insider sale
Chief Medical Officer at FENNEC PHARMACEUTICALS INC. — senior position signals high conviction
$146.2K
12K shares
What this filing means
SAYAD PIERRE SARGIS plans to sell 12K shares of FENNEC PHARMACEUTICALS INC. valued at approximately $146.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/31/2026ACC: 0001950047-26-008849
Officer· Chief Medical Officer
Since Oct 2024
12K
Shares to sell
$146.2K
Approx. market value
12K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months6
Restricted Stock
Not Applicable
7/31/2026
168.00Restricted Stock
Not Applicable
6/30/2026
168.00Restricted Stock
Not Applicable
5/31/2026
168.00Restricted Stock
Not Applicable
4/30/2026
168.00Performance Shares
Not Applicable
3/31/2026
11.16KRestricted Stock
Not Applicable
3/31/2026
171.00Total acquired12K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/31/2026 | Restricted Stock Not Applicable | 168.00 | — |
6/30/2026 | Restricted Stock Not Applicable | 168.00 | — |
5/31/2026 | Restricted Stock Not Applicable | 168.00 | — |
4/30/2026 | Restricted Stock Not Applicable | 168.00 | — |
3/31/2026 | Performance Shares Not Applicable | 11.16K | — |
3/31/2026 | Restricted Stock Not Applicable | 171.00 | — |
| Total | 12K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
12K
Market value
$146.2K
8/31/2026
Total
Units
12K
Value
$146.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/31/2026 | 12K | $146.2K | NASDAQ | Planned |
| Total | 12K | $146.2K | ||